Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson’s disease

被引:0
作者
Eleonora Fiorenzato
Angelo Antonini
Valeria Camparini
Luca Weis
Carlo Semenza
Roberta Biundo
机构
[1] IRCCS San Camillo Hospital,Department of Neurosciences, Padova Neuroscience Center
[2] University of Padua,undefined
来源
Journal of Neural Transmission | 2019年 / 126卷
关键词
Progressive supranuclear palsy; Parkinson’s disease; Longitudinal study; Verbal fluency; Visuospatial functions; Executive functions;
D O I
暂无
中图分类号
学科分类号
摘要
Cognitive impairment is frequent in progressive supranuclear palsy (PSP) and less common in multiple system atrophy (MSA), but characteristics and progression compared with Parkinson’s disease (PD) need to be properly defined. We evaluated 35 PSP with Richardson’s syndrome (PSP-RS), 30 MSA as well as 65 age-, sex-, and education-matched PD with an extensive clinical and neuropsychological assessment, allowing Level II cognitive diagnosis. Eighteen PSP, 12 MSA and 30 PD had a second evaluation between 12 and 18 months (mean 15 months) after the first assessment. PSP performance at Montreal Cognitive Assessment (MoCA), verbal fluencies (phonemic and semantic tasks), Stroop test (Error and Time), Digit Span Sequencing (DSS), incomplete letters of Visual Object and Space Perception (VOSP) and Benton’s Judgment of Line Orientation (JLO) performance were significantly poorer at baseline compared to PD and MSA. Executive, language and visuospatial abilities declined longitudinally in PSP, but not in PD and MSA. After 1.5 year, 16% of PSP converted to dementia. Our study provides evidence that cognitive progression is more severe and rapid in PSP-RS than PD and MSA. Further, we observed that MoCA, verbal fluency (particularly semantic), DSS and Benton’s JLO are valuable tests to detect cognitive progression in PSP-RS and may be proposed as possible biomarker to assess efficacy of disease modification strategies.
引用
收藏
页码:1437 / 1445
页数:8
相关论文
共 327 条
  • [51] Halliday GM(undefined)undefined undefined undefined undefined-undefined
  • [52] Velakoulis D(undefined)undefined undefined undefined undefined-undefined
  • [53] Wood SJ(undefined)undefined undefined undefined undefined-undefined
  • [54] Stuart GW(undefined)undefined undefined undefined undefined-undefined
  • [55] Currie J(undefined)undefined undefined undefined undefined-undefined
  • [56] Soo M(undefined)undefined undefined undefined undefined-undefined
  • [57] Olivieri G(undefined)undefined undefined undefined undefined-undefined
  • [58] Broe GA(undefined)undefined undefined undefined undefined-undefined
  • [59] Morris JGL(undefined)undefined undefined undefined undefined-undefined
  • [60] Dubois B(undefined)undefined undefined undefined undefined-undefined